ong-Term Follow-Up of Subjects Treated With NTLA-2002
Phase 1
Recruiting
- Conditions
- Hereditary AngioedemaMedDRA version: 20.0Level: PTClassification code: 10019860Term: Hereditary angioedema Class: 100000004850Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Registration Number
- CTIS2023-507956-56-00
- Lead Sponsor
- Intellia Therapeutics Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
A subject has completed or discontinued from an Intellia-sponsored or -supported treatment protocol in which a complete or partial dose of NTLA-2002 was received., A subject has provided informed consent for the LTFU study, A subject is willing to attend study visits, complete protocol-required follow-up schedule, and comply with the study requirements.
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method